Healthcare Value Capital as of Sept. 30, 2018
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 12 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 18.7 | $7.7M | 100k | 77.21 | |
| Amarin Corporation (AMRN) | 17.7 | $7.3M | 450k | 16.27 | |
| Tyme Technologies | 14.6 | $6.0M | 2.2M | 2.78 | |
| GlaxoSmithKline | 9.7 | $4.0M | 100k | 40.17 | |
| Allergan | 9.2 | $3.8M | 20k | 190.50 | |
| D Fluidigm Corp Del (LAB) | 8.2 | $3.4M | 450k | 7.49 | |
| Noveliontherapeuti.. | 7.2 | $3.0M | 1.0M | 2.96 | |
| Viking Therapeutics (VKTX) | 6.3 | $2.6M | 150k | 17.42 | |
| Proshares Tr ultsh nasd biot | 5.7 | $2.3M | 150k | 15.63 | |
| Antares Pharma | 2.0 | $840k | 250k | 3.36 | |
| Lannett Company | 0.6 | $238k | 50k | 4.76 | |
| Apricus Biosciences | 0.1 | $31k | 100k | 0.31 |
